Chu de Bordeaux

France

 
Quantité totale PI 20
Rang # Quantité totale PI 74 222
Note d'activité PI 1,9/5.0    12
Rang # Activité PI 73 276

Brevets

Marques

3 0
0 0
17 0
0
 
Dernier brevet 2024 - Methods of preventing on-target ...
Premier brevet 2013 - Matrix metalloproteinase 9 (mmp-...

Derniers inventions, produits et services

2024 Invention Methods of preventing on-target genotoxicity induced by nucleases. The CRISPR-Cas9 system has rev...
2023 Invention Use of nrf2 activators for the treatment of cerebral small vessel disease. Cerebral small vessel ...
2021 Invention 3d bioprinting method for forming a cell specific tissue construct. in vitroin vitro tissue/organ...
Invention Methods for predicting acute severe colitis treatment response. The present invention relates to...
2020 Invention An ubiquitin ligase inhibitor for use for preventing and/or treating a disease linked with cerebr...
Invention Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction. ...
Invention Bcl-xl:fkbp12 fusion proteins suitable for screening agents capable of slowing down the aging pro...
Invention The double deamidated form of bcl-xl is a biomarker of platelet age. Deamidation is usually view...
Invention The double deamidated form of bcl-xl is a biomarker of platelet age. Deamidation is usually viewe...
2019 Invention Methods of predicting the risk of having lower-extremity artery disease in patients suffering fro...
2018 Invention Use of fzd7 inhibitors for the treatment of retinal neovascularization. In vivoIn vivo intravitre...
Invention Methods and pharmaceutical compositions for reducing cd95- mediated cell motility. The present i...
Invention Methods and pharmaceutical compositions for reducing cd95- mediated cell motility. The present in...
2017 Invention Pharmaceutical compositions for the treatment of endothelial dysfunction. Endothelial dysfunction...
Invention Methods for determining whether a patient suffering from a myeloproliferative neoplasm is at risk...
Invention Methods for predicting acute severe colitis treatment response. The present invention relates to ...
2016 Invention A method for quantifying bevacizumab. The present invention relates to the use of an Internal Sta...
Invention Methods and pharmaceutical compositions for the treatment of ebola virus disease. The invention r...
2015 Invention Methods and kits for predicting medically refractory acute severe colitis. The present invention ...
2013 Invention Matrix metalloproteinase 9 (mmp-9) aptamer and uses thereof. The present invention relates to a ...
Invention Matrix metalloproteinase 9 (mmp-9) aptamer and uses thereof. The present invention relates to a n...